1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Synthes

Anonymous board for Synthes


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    34
    Views:
    6,169
  2. anonymous
    Replies:
    41
    Views:
    7,188
  3. anonymous
    Replies:
    2
    Views:
    3,420
  4. anonymous
    Replies:
    28
    Views:
    8,219
  5. anonymous
    Replies:
    3
    Views:
    1,376
  6. anonymous
    Replies:
    6
    Views:
    2,532
  7. anonymous
    Replies:
    28
    Views:
    7,270
  8. Anonymous
    Replies:
    5
    Views:
    2,466
  9. anonymous
    Replies:
    7
    Views:
    3,850
  10. anonymous
    Replies:
    37
    Views:
    18,063
  11. anonymous
    Replies:
    0
    Views:
    864
  12. Anonymous
    Replies:
    13
    Views:
    10,508
  13. Anonymous
    Replies:
    9
    Views:
    3,773
  14. Former DS Trauma Rep
    Replies:
    4
    Views:
    2,757
  15. anonymous
    Replies:
    2
    Views:
    1,735
  16. anonymous
    Replies:
    6
    Views:
    3,700
  17. anonymous
    Replies:
    3
    Views:
    1,658
  18. anonymous
    Replies:
    13
    Views:
    3,624
  19. Anonymous
    Replies:
    6
    Views:
    6,760
  20. anonymous
    Replies:
    18
    Views:
    2,873

Thread Display Options

Loading...